Bulletin de Périodique
International Journal of Drug Policy , Vol.76 - February 2020
Paru le :
01/02/2020
Année :
2020
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Editing the International Journal of Drug Policy [Editorial]. Rhodes T., Ritter A., p. 102664.
- Integration of harm reduction and treatment into care centres for substance use: The Barcelona model [Editorial]. Pares-Badell O., Barbaglia G., Robinowitz N., Majo X., Torrens M., Espelt A., et al., p. 102614.
- A national case fatality study of drugs taken in intentional overdose. Daly C., Griffin E., Corcoran P., Webb R.T., Ashcroft D.M., Perry I.J., et al., p. 102609.
- Critical studies of harm reduction: Overdose response in uncertain political times. Watson T.M., Kolla G., van der Meulen E., Dodd Z., p. 102615.
- Opioid-related deaths in Europe: Strategies for a comprehensive approach to address a major public health concern. Alho H., Dematteis M., Lembo D., Maremmani I., Roncero C., Somaini L., p. 102616.
- Help me fix: The provision of injection assistance at an unsanctioned overdose prevention site in Toronto, Canada. Kolla G., Kenny K.S., Bannerman M., Boyce N., Chapman L., Dodd Z., et al., p. 102617.
- Police-related barriers to harm reduction linked to non-fatal overdose amongst sex workers who use drugs: Results of a community-based cohort in Metro Vancouver, Canada. Goldenberg S., Watt S., Braschel M., Hayashi K., Moreheart S., Shannon K., p. 102618.
- Frequency of injecting among people who inject drugs: A systematic review and meta-analysis. Colledge S., Leung J., Larney S., Peacock A., Grebely J., Hickman M., et al., p. 102619.
- "It's like super structural" - Overdose experiences of youth who use drugs and police in three non-metropolitan cities across British Columbia. Selfridge M., Greer A., Card K.G., Macdonald S., Pauly B., p. 102623.
- Estimated effect of US state syringe sale policy on source of last-used injection equipment. Janulis P., Montgomery B.W., Anthony J.C., p. 102625.
- The price and mark up of pharmaceutical drugs supplied on the black market. Hulme S., Hughes C.E., Nielsen S., p. 102626.
- The Dark Web and cannabis use in the United States: Evidence from a big data research design. Jardine E., Lindner A.M., p. 102627.
- MDMA-related deaths in Australia 2000 to 2018. Roxburgh A., Lappin J., p. 102630.
- Emerging prospects for non-medical cannabis legalisation in New Zealand: An initial view and contextualization. Fischer B., Bullen C., p. 102632.
- A cost-effectiveness analysis of primary versus hospital-based specialist care for direct acting antiviral hepatitis C treatment. Palmer A.Y., Wade A.J., Draper B., Howell J., Doyle J.S., Petrie D., et al., p. 102633.
- Reputation transferability across contexts: Maintaining cooperation among anonymous cryptomarket actors when moving between markets. Norbutas L., Ruiter S., Corten R., p. 102635.
- Estimating the size of crack cocaine users in France: Methods for an elusive population with high heterogeneity. Janssen E., Cadet-Taïrou A., Gérome C., Vuolo M., p. 102637.
- Predictors of work engagement among Australian non-government drug and alcohol employees: Implications for policy and practice. Duraisingam V., Roche A.M., Kostadinov V., Hodge S., Chapman J., p. 102638.
- Divergences and commonalities between the US opioid crisis and prescription medicine mis/use in West Africa. Klein A., Patwardhan S., Loglo M.G.A., p. 102640.
- Women's utilization of housing-based overdose prevention sites in Vancouver, Canada: An ethnographic study. Collins A.B., Boyd J., Hayashi K., Cooper H.L.F., Goldenberg S., McNeil R., p. 102641.
- Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone. Schneider K.E., O'Rourke A., White R.H., Park J.N., Musci R.J., Kilkenny M.E., et al., p. 102642.
- Message framing to reduce stigma and increase support for policies to improve the wellbeing of people with prior drug convictions. Bandara S.N., McGinty E.E., Barry C.L., p. 102643.
- The relationships between chronic pain and changes in health with cannabis consumption patterns. Cooke A., Chavez L., Freisthler B., p. 102657.
- Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets. Goodman S., Wadsworth E., Leos-Toro C., Hammond D., p. 102658.
- Prevalence, frequency, and motivations for alkyl nitrite use among gay, bisexual and other men who have sex with men in Australia. Vaccher S.J., Hammoud M.A., Bourne A., Lea T., Haire B.G., Holt M., et al., p. 102659.
- Editing the International Journal of Drug Policy [Editorial]. Rhodes T., Ritter A., p. 102664.
- Integration of harm reduction and treatment into care centres for substance use: The Barcelona model [Editorial]. Pares-Badell O., Barbaglia G., Robinowitz N., Majo X., Torrens M., Espelt A., et al., p. 102614.
- A national case fatality study of drugs taken in intentional overdose. Daly C., Griffin E., Corcoran P., Webb R.T., Ashcroft D.M., Perry I.J., et al., p. 102609.
- Critical studies of harm reduction: Overdose response in uncertain political times. Watson T.M., Kolla G., van der Meulen E., Dodd Z., p. 102615.
- Opioid-related deaths in Europe: Strategies for a comprehensive approach to address a major public health concern. Alho H., Dematteis M., Lembo D., Maremmani I., Roncero C., Somaini L., p. 102616.
- Help me fix: The provision of injection assistance at an unsanctioned overdose prevention site in Toronto, Canada. Kolla G., Kenny K.S., Bannerman M., Boyce N., Chapman L., Dodd Z., et al., p. 102617.
- Police-related barriers to harm reduction linked to non-fatal overdose amongst sex workers who use drugs: Results of a community-based cohort in Metro Vancouver, Canada. Goldenberg S., Watt S., Braschel M., Hayashi K., Moreheart S., Shannon K., p. 102618.
- Frequency of injecting among people who inject drugs: A systematic review and meta-analysis. Colledge S., Leung J., Larney S., Peacock A., Grebely J., Hickman M., et al., p. 102619.
- "It's like super structural" - Overdose experiences of youth who use drugs and police in three non-metropolitan cities across British Columbia. Selfridge M., Greer A., Card K.G., Macdonald S., Pauly B., p. 102623.
- Estimated effect of US state syringe sale policy on source of last-used injection equipment. Janulis P., Montgomery B.W., Anthony J.C., p. 102625.
- The price and mark up of pharmaceutical drugs supplied on the black market. Hulme S., Hughes C.E., Nielsen S., p. 102626.
- The Dark Web and cannabis use in the United States: Evidence from a big data research design. Jardine E., Lindner A.M., p. 102627.
- MDMA-related deaths in Australia 2000 to 2018. Roxburgh A., Lappin J., p. 102630.
- Emerging prospects for non-medical cannabis legalisation in New Zealand: An initial view and contextualization. Fischer B., Bullen C., p. 102632.
- A cost-effectiveness analysis of primary versus hospital-based specialist care for direct acting antiviral hepatitis C treatment. Palmer A.Y., Wade A.J., Draper B., Howell J., Doyle J.S., Petrie D., et al., p. 102633.
- Reputation transferability across contexts: Maintaining cooperation among anonymous cryptomarket actors when moving between markets. Norbutas L., Ruiter S., Corten R., p. 102635.
- Estimating the size of crack cocaine users in France: Methods for an elusive population with high heterogeneity. Janssen E., Cadet-Taïrou A., Gérome C., Vuolo M., p. 102637.
- Predictors of work engagement among Australian non-government drug and alcohol employees: Implications for policy and practice. Duraisingam V., Roche A.M., Kostadinov V., Hodge S., Chapman J., p. 102638.
- Divergences and commonalities between the US opioid crisis and prescription medicine mis/use in West Africa. Klein A., Patwardhan S., Loglo M.G.A., p. 102640.
- Women's utilization of housing-based overdose prevention sites in Vancouver, Canada: An ethnographic study. Collins A.B., Boyd J., Hayashi K., Cooper H.L.F., Goldenberg S., McNeil R., p. 102641.
- Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone. Schneider K.E., O'Rourke A., White R.H., Park J.N., Musci R.J., Kilkenny M.E., et al., p. 102642.
- Message framing to reduce stigma and increase support for policies to improve the wellbeing of people with prior drug convictions. Bandara S.N., McGinty E.E., Barry C.L., p. 102643.
- The relationships between chronic pain and changes in health with cannabis consumption patterns. Cooke A., Chavez L., Freisthler B., p. 102657.
- Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets. Goodman S., Wadsworth E., Leos-Toro C., Hammond D., p. 102658.
- Prevalence, frequency, and motivations for alkyl nitrite use among gay, bisexual and other men who have sex with men in Australia. Vaccher S.J., Hammoud M.A., Bourne A., Lea T., Haire B.G., Holt M., et al., p. 102659.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
O. PARES-BADELL ;
G. BARBAGLIA ;
N. ROBINOWITZ ;
X. MAJO ;
M. TORRENS ;
A. ESPELT ;
M. BARTROLI ;
M. GOTSENS ;
M. T. BRUGAL
|
2020
Dans International Journal of Drug Policy (Vol.76, February 2020) Article : Périodique
Dans International Journal of Drug Policy (Vol.76, February 2020) Article : Périodique
The Barcelona model consists of offering harm reduction services - including drug consumption rooms (DCR) - hand-in-hand with substance use treatment programmes in care centres for substance use. The Barcelona model integrates different interven[...]
H. ALHO ;
M. DEMATTEIS ;
D. LEMBO ;
I. MAREMMANI ;
C. RONCERO ;
L. SOMAINI
|
2020
Dans International Journal of Drug Policy (Vol.76, February 2020) Article : Périodique
Dans International Journal of Drug Policy (Vol.76, February 2020) Article : Périodique
Use of illicit opioids and misuse of prescription opioids are the main causes of drug-related deaths across the world, and the continuing rise in opioid-related mortality, especially affecting North America, Australia and Europe, is a public hea[...]
S. COLLEDGE ;
J. LEUNG ;
S. LARNEY ;
A. PEACOCK ;
J. GREBELY ;
M. HICKMAN ;
E. CUNNINGHAM ;
A. TRICKEY ;
J. STONE ;
P. VICKERMAN ;
L. DEGENHARDT
|
2020
Dans International Journal of Drug Policy (Vol.76, February 2020) Article : Périodique
Dans International Journal of Drug Policy (Vol.76, February 2020) Article : Périodique
BACKGROUND: People who inject drugs (PWID) do so at varying frequencies. More frequent injecting is associated with skin and soft tissue infection, blood borne viruses, and overdose. The aims of this review are to estimate the prevalence of inje[...]
M. SELFRIDGE ;
A. GREER ;
K. G. CARD ;
S. MACDONALD ;
B. PAULY
|
2020
Dans International Journal of Drug Policy (Vol.76, February 2020) Article : Périodique
Dans International Journal of Drug Policy (Vol.76, February 2020) Article : Périodique
INTRODUCTION: Youth who use drugs (YWUD) are vulnerable to experience or encounter drug related overdose deaths. Fentanyl has increased the risks, calling greater attention to overdose. In response, there have been increases in harm reduction se[...]
E. JARDINE ;
A. M. LINDNER
|
2020
Dans International Journal of Drug Policy (Vol.76, February 2020) Article : Périodique
Dans International Journal of Drug Policy (Vol.76, February 2020) Article : Périodique
BACKGROUND: Cannabis is one of the most commonly sold drugs on cryptomarkets. Because of the anonymity-granting functions of Tor, no study has traced the within-country effect of the Dark Web on cannabis consumption patterns. This article uses a[...]
E. JANSSEN ;
A. CADET-TAÏROU ;
C. GEROME ;
M. VUOLO
|
2020
Dans International Journal of Drug Policy (Vol.76, February 2020) Article : Périodique
Dans International Journal of Drug Policy (Vol.76, February 2020) Article : Périodique
Background: Despite several sources corroborating an expanding market and increased visibility and greater diversity in users' profiles, very little is known about the number of crack cocaine users in France.
Method: The estimates rely on a sin[...]
S. GOODMAN ;
E. WADSWORTH ;
C. LEOS-TORO ;
D. HAMMOND ;
International Cannabis Policy Study team
|
2020
Dans International Journal of Drug Policy (Vol.76, February 2020) Article : Périodique
Dans International Journal of Drug Policy (Vol.76, February 2020) Article : Périodique
BACKGROUND: Recreational or 'non-medical cannabis' has been legalized in several US states, and was legalized federally in Canada in October 2018. There is little comparative data on product use across jurisdictions, particularly with respect to[...]